In a randomized clinical trial, giving the clot-busting medication alteplase up to 24 hours after stroke symptoms first appeared increased the odds of better recovery by 50% compared to those who ...
LOS ANGELES -- For patients with large vessel occlusion (LVO) strokes, researchers found ways to make adjunctive ...
In a randomized clinical trial in China, giving the clot-busting medication alteplase up to 24 hours after stroke symptoms ...
Use of endovascular thrombectomy in patients with acute ischemic stroke caused by occlusions in distal vessels has failed to ...
One in six deaths from cardiovascular disease in the United States is due to stroke, and over 100 million people worldwide have had a stroke, which is a leading cause of serious long-term disability.
Revalesio updates new analyses from phase 2 RESCUE clinical study of RNS60 in patients with acute ischemic stroke: Tacoma, Washington Friday, February 7, 2025, 18:00 Hrs [IST] Rev ...
Wellumio has enrolled the first subject in the Portable MRI study of its magnetic resonance imaging (MRI) device, 'Axana' 0.1T, for stroke identification in emergency department patients. The two-part ...
Hyperfine reports on new data at ISC 2025 showcasing the growing potential for using images from AI-powered portable MRI for ...
MIND was a prospective, open-label trial that enrolled adults up to 80 years old with moderate-large (20-80 mL) ...
Three trials showed no improvement in functional outcomes, and the potential for harm, versus medical therapy alone.
Mechanically retrieving a blood clot blocking a medium- or small-sized brain artery was no better at reducing disability 90 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback